Evidence map›Paper›PMID 18165316›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

An alcohol binding site on the neural cell adhesion molecule L1.

Enrique Arevalo, Sivananthaperumal Shanmugasundararaj, Michael F Wilkemeyer, Xiaowei Dou, Suzhen Chen, Michael E Charness, Keith W Miller

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Fetal alcohol spectrum disorders.Nature reviews. Disease primers · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. SNARE Complex-Associated Proteins and Alcohol.Alcoholism, clinical and experimental research · 2020
    Review
  16. Article
  17. L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  18. Article
  19. Titrating Tipsy Targets: The Neurobiology of Low-Dose Alcohol.Trends in pharmacological sciences · 2017
    Review
  20. Gene-environment interactions in development and disease.Wiley interdisciplinary reviews. Developmental biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Enrique ArevaloDepartment of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, MA 02114, USA.
Sivananthaperumal Shanmugasundararaj
Michael F Wilkemeyer
Xiaowei Dou
Suzhen Chen
Michael E Charness
Keith W Miller
Massachusetts General Hospital · USVA Boston Healthcare System · USHarvard University · US

Funding

ALCOHOL AND CELL ADHESIONR37AA012974 · NIAAA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CHARNESS, MICHAEL EDWARD · 2002 to 2010
$4.3M
ALCOHOL AND CELL ADHESIONR01AA012974 · NIAAA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CHARNESS, MICHAEL EDWARD · 2001 to 2016
$2.4M
Photolabeling of alcohol binding sites L1:U01AA014812 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, KEITH W · 2003 to 2005
$731k
NIAAA NIH HHS AA12974NIAAA NIH HHS R01 AA012974NIAAA NIH HHS R37 AA012974NIAAA NIH HHS U01 AA014812
6 · The paper itself

Abstract

Prenatal ethanol exposure causes fetal alcohol spectrum disorders (FASD) in part by disrupting the neural cell adhesion molecule L1. L1 gene mutations cause neuropathological abnormalities similar to those of FASD. Ethanol and 1-butanol inhibit L1-mediated cell-cell adhesion (L1 adhesion), whereas 1-octanol antagonizes this action. To test the hypothesis that there are alcohol binding sites on L1, we used 3-azibutanol and 3-azioctanol, the photoactivatable analogs of 1-butanol and 1-octanol, to photolabel the purified Ig1-4 domain of human L1 (hL1 Ig1-4). 3-Azibutanol (11 mM), like ethanol, inhibited L1 adhesion in NIH/3T3 cells stably transfected with hL1, whereas subanesthetic concentrations of 3-azioctanol (14 microM) antagonized ethanol inhibition of L1 adhesion. 3-Azibutanol (100-1,000 microM) and 3-azioctanol (10-100 microM) photoincorporated into Tyr-418 on Ig4 and into two adjacent regions in the N terminus, Glu-33 and Glu-24 to Glu-27. A homology model of hL1 Ig1-4 (residues 33-422), based on the structure of the Ig1-4 domains of axonin-1, suggests that Glu-33 and Tyr-418 hydrogen-bond at the interface of Ig1 and Ig4 to stabilize a horseshoe conformation of L1 that favors homophilic binding. Furthermore, this alcohol binding pocket lies within 7 A of Leu-120 and Gly-121, residues in which missense mutations cause neurological disorders similar to FASD. These data suggest that ethanol or selected mutations produce neuropathological abnormalities by disrupting the domain interface between Ig1 and Ig4. Characterization of alcohol agonist and antagonist binding sites on L1 will aid in understanding the molecular basis for FASD and might accelerate the development of ethanol antagonists.

Indexed as

AlcoholsAnimalsBinding SitesButanolsCell AdhesionCell Adhesion MoleculesDiazomethaneEthanolHydrogen BondingLightMass SpectrometryMiceModels, BiologicalModels, GeneticMolecular ConformationNeural Cell Adhesion Molecule L13-azibutanolAlcoholsButanolsCell Adhesion MoleculesDiazomethaneEthanolNeural Cell Adhesion Molecule L1

Identifiers

PMID18165316
PMCPMC2224219
OpenAlexW1995958961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.